Abstract
The most common diagnosis for pediatric thrombocytopenia is immune thrombocytopenia. Nevertheless, in atypical cases, the hypothesis of an inherited thrombocytopenia has to be investigated. We report a series of cases of a newly described entity, genetic thrombocytopenia with mutation in the ankyrine 26 gene, diagnosed from the exploration of five pediatric cases of thrombocytopenia. This entity is characterized by a moderate thrombocytopenia with normal mean platelet volume, and poorly bleeding. Its transmission is autosomal dominant. Final diagnosis is made by sequencing of a short DNA region of ANKRD26 gene. This pathology can be considered as an hematological malignancy predisposition syndrome.
Conclusion: We report the first cohort of pediatric patients diagnosed with thrombocytopenia with mutation in the ankyrine 26. The aim is to underline the specificities of this entity in children and bring it to the knowledge of pediatricians who may be in first place to manage these patients.
What is Known: |
• Genetic thrombocytopenia with mutation in the ankyrine 26 gene is a recently described entity, which seems to be considered as a predisposition for hematologic malignancies. • The first cohort has been reported in 2011, by Noris et al., in 78 Italian adult patients. |
What is New: |
• We describe clinical and biological features of the first pediatric cohort diagnosed with genetic thrombocytopenia with mutation in the ankyrine 26 gene. • It seemed important to consider the pediatric specificities of this entity to enable pediatricians to investigate, diagnose, and manage pediatric patients and their families. |
Abbreviations
- ANKRD26:
-
Ankyrine 26
- CD:
-
Cluster differentiation
- GP:
-
Glycoprotein
- ITP:
-
Immune thrombocytopenia
- MPV:
-
Mean platelet volume
- TPO:
-
Thrombopoietin
- UTR:
-
Untranslated region
References
Balduini CL, Pecci A, Noris P (2013) Diagnosis and management of inherited thrombocytopenias. Semin Thromb Hemost 39(2):161–71
Balduini CL, Pecci A, Noris P (2012) Inherited thrombocytopenias: the evolving spectrum. Hamostaseologie 32(4):259–70
Bluteau D, Balduini A, Balayn N, Currao M, Nurden P, Deswarte C et al (2014) Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation. J Clin Invest 124(2):580–91
Drachman JG (2004) Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood 103(2):390–8
Necchi V, Balduini A, Noris P, Barozzi S, Sommi P, di Buduo C et al (2013) Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. Thromb Haemost 109(2):263–71
Noris P, Favier R, Alessi M-C, Geddis AE, Kunishima S, Heller PG et al (2013) ANKRD26-related thrombocytopenia and myeloid malignancies. Blood 122(11):1987–9
Noris P, Perrotta S, Seri M, Pecci A, Gnan C, Loffredo G et al (2011) Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood 117(24):6673–80
Pippucci T, Savoia A, Perrotta S, Pujol-Moix N, Noris P, Castegnaro G et al (2011) Mutations in the 5’ UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2. Am J Hum Genet 88(1):115–20
Conflict of interest statement
The authors have no conflict of interest to disclose for this work.
Authors’ contributions
HB collected the data and wrote the manuscript. GL, AA, and AP followed the patients in consultations. HL, PB, and RF performed biological analyses and genotyping assays. All the authors reviewed and approved the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by David Nadal
Revisions received: 11 February 2015 / 12 April 2015
Rights and permissions
About this article
Cite this article
Boutroux, H., Petit, A., Auvrignon, A. et al. Childhood diagnosis of genetic thrombocytopenia with mutation in the ankyrine repeat domain 26 gene. Eur J Pediatr 174, 1399–1403 (2015). https://doi.org/10.1007/s00431-015-2549-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-015-2549-x